Pay in 4 interest-free payments of $27.00 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Pomalidomide4PEG3amine
393105-53-8
and this is accompanied by 59% inhibition of tumor growth
The small molecule inhibitor
Smiles: CCC1=NN(CCO)C(CC)=C1OC1C=C(C=C(C=1)C#N)C#N
TAK-875 er-5 Pomalidomide4PEG3amineTAK 875, is a potent, selective, and orally bioavailable GPR40 agonist, with a pharmacokinetic profile enabling long acting drug efficacy. TAK 875 showed potent plasma glucose lowering action and insulinotropic action during an oral glucose tolerance test in female Wistar fatty rats with impaired glucose tolerance. TAK 875 is currently in clinical trials for the treatment of type 2 diabetes mellitus. Product information CAS Number: 1000413 72 8